In March 2022, Ceva Santé Animale launched a series of interviews covering several aspects of Gumboro disease control. In the episodes shared so far, poultry experts from all around the world, discussed about very important aspects for proper Gumboro control, their experiences from Asia to Latin America, how to diagnose the disease, and the impacts on the performance of the broilers flocks.
Among the episodes, there are some very special interviews, like when Tune in with experts visited Padova University, in Italy, to talk to Mattia Cecchinato and Matteo Legnardi about the studies that their lab are conducting, and the new finding of IBD strains in the field.
They are running important monitoring studies, analysing the VP1 and VP2 of these strains, detecting reassortant IBD strains. During this episode our audience will be able understand the impact of these IBD strains, and how to control it.
And how not mention the 3 interviews with one of the most important figures of the poultry industry, Vilmos Palya, who has decades of experience controlling Gumboro disease, he has a special role not just in developing vaccines, diagnosis protocols, but also in advising hundreds of vets around the world.
Take a look at one of the videos featuring Vilmos Palya
Scan the QR code below to go directly to the YouTube page and watch the videos from the series.
We hope you enjoy the videos.
"*" indicates required fields
Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: “Together, beyond animal health”. 2022 turnover: €1.53 billion. Use the links below to learn more about Ceva.
Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: “Together, beyond animal health”. 2022 turnover: €1.53 billion. Use the links below to learn more about Ceva.
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (18) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.